RXD:NYE-ProShares UltraShort Health Care (USD)

ETF | Trading--Inverse Equity |

Last Closing

USD 10.23

Change

-0.21 (-2.02)%

Market Cap

N/A

Volume

9.10K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-25 )

Largest Industry Peers for Trading--Inverse Equity

Symbol Name Price(Change) Market Cap
SH ProShares Short S&P500

+0.21 (+0.50%)

USD 0.96B
SOXS Direxion Daily Semiconductor B..

+1.30 (+6.44%)

USD 0.61B
PSQ ProShares Short QQQ

+0.47 (+1.27%)

USD 0.50B
SPXU ProShares UltraPro Short S&P50..

+0.34 (+1.58%)

USD 0.48B
SDOW ProShares UltraPro Short Dow30

-0.49 (-1.02%)

USD 0.26B
YANG Direxion Daily FTSE China Bear..

-1.37 (-3.09%)

USD 0.22B
FNGD MicroSectors FANG+ Index -3X I..

+0.64 (+4.83%)

USD 0.14B
RWM ProShares Short Russell2000

+0.06 (+0.31%)

USD 0.14B
SPDN Direxion Daily S&P 500® Bear ..

+0.06 (+0.55%)

USD 0.14B
DUST Direxion Daily Gold Miners Ind..

+1.44 (+3.11%)

USD 0.13B

ETFs Containing RXD

RLD:CA 0.00 % 0.61 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Inverse Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -14.03% 20% F 7% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return -14.03% 20% F 7% C-
Trailing 12 Months  
Capital Gain -2.25% 95% A 27% F
Dividend Return 3.98% 77% C+ 60% D-
Total Return 1.74% 95% A 28% F
Trailing 5 Years  
Capital Gain -73.93% 69% C- 5% F
Dividend Return 2.32% 66% D+ 6% D-
Total Return -71.61% 69% C- 4% F
Average Annual (5 Year Horizon)  
Capital Gain 64.30% 40% F 95% A
Dividend Return 65.62% 40% F 95% A
Total Return 1.32% 60% D- 31% F
Risk Return Profile  
Volatility (Standard Deviation) 433.52% 62% D 3% F
Risk Adjusted Return 15.14% 49% F 30% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.